论文部分内容阅读
目的:探究尿激酶静脉溶栓治疗急性心肌梗死的临床效果观察。方法:将本院收治的50例急性心肌梗死患者作为研究对象(2012年2月至2017年2月),并根据治疗方式不同将其随机分为对照组(常规治疗方式)和观察组(尿激酶静脉溶栓治疗),每组25例。对比两组患者治疗前后主要临床症状的变化情况以及临床治疗效果。结果:2组患者治疗前后主要临床症状的变化情况以及临床治疗比较且观察组明显优于对照组(P<0.05)。结论:尿激酶静脉溶栓治疗对急性心肌梗死患者有更好的治疗作用。
Objective: To investigate the clinical effect of intravenous thrombolytic therapy of urokinase on acute myocardial infarction. Methods: Fifty patients with acute myocardial infarction admitted to our hospital from February 2012 to February 2017 were randomly divided into control group (conventional treatment) and observation group (urine) according to different treatment methods Kinase intravenous thrombolysis), 25 cases in each group. The changes of major clinical symptoms before and after treatment were compared between two groups of patients and the effect of clinical treatment. Results: Before and after treatment, the changes of the main clinical symptoms and clinical treatment of the two groups were better than those of the control group (P <0.05). Conclusion: Thrombolytic therapy of urokinase has a better therapeutic effect on patients with acute myocardial infarction.